Robert Coury - Mylan

Robert Coury - Mylan
Total Compensation: $21.3 million

Details: Coury took a bit of a pay cut in his final year as Mylan's ($MYL) chief after steady raises from 2008 to 2010. His base salary jumped by about $800,000 to $1.78 million, and he saw increases in stock awards and incentive compensation, but his deferred compensation dropped by more than $3 million.

Coury will stay on as executive chairman of the genericsmaker, which plans to broaden its sales by launching its own prescription drugs in India, and Mylan is optimistic that the $17.5 million it paid for Pfizer's dry powder inhaler technology will help the company carve out a space in the world respiratory market.

Read More:
Robert Coury - Mylan